An Australian perspective on COVID-19 vaccine candidates with Professor Terry Nolan

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/b5/51/e7/b551e72b-bc7a-a10a-b90a-95f919c6b41a/mza_10872013384498953585.jpg/600x600bb.jpg

COVID19 Road to a vaccine

MVEC

18 episodes

8 months ago

The year 2020 has seen the emergence of the SARS-CoV-2 virus (COVID19), a unique and potentially devastating virus, with no known prevention or treatment. This new SARS-CoV-2 virus has shown to not only have significant international health implications, but also immense psychological and economic impacts. Associate Professor Nigel Crawford, a vaccinologist and consultant paediatrician at the Murdoch Children’s Research Institute (MCRI) & Royal Children’s Hospital (RCH), Melbourne, will delve into the global pursuit of a safe and effective vaccine to prevent COVID19. This is all occurring at ‘pandemic speed’ and MVEC’s new podcast will explore this complicated and multi-faceted process through interviews with a variety of national and international vaccine experts.

Medicine

Health & Fitness

RSS

All content for COVID19 Road to a vaccine is the property of MVEC and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/89a7f3d037c7a3c66e8b53401be97e50.jpg

An Australian perspective on COVID-19 vaccine candidates with Professor Terry Nolan

COVID19 Road to a vaccine

22 minutes

5 years ago

An Australian perspective on COVID-19 vaccine candidates with Professor Terry Nolan

In episode 5 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford speaks to Professor Terry Nolan. Professor Nolan is a Redmond Barry Distinguished Professor at the Doherty Institute for Infection and Immunity. He heads up VIRGO, the vaccine and immunisation research group, a collaboration between Murdoch Children's Research Institute and the University of Melbourne. VIRGO has the largest and longest standing child and adolescent vaccine population research and clinical trials program in Australia. He previously chaired ATAGI, the Australian Technical Advisory Group on Immunisation and was a member of SAGE, the World Health Organisation's main advisory group on vaccines and immunisation. They discuss the COVID-19 candidate vaccines from an Australian perspective and Australia's role in global clinical trials.

Links:

•The Lancet: A real time dashboard of clinical trials for COVID-19:
https://www.thelancet.com/journals/landig/article/PIIS2589-7500(20)30086-8/fulltext?utm_campaign=tlcoronavirus20&utm_source=twitter&utm_medium=social#relAudio

•ClinicalTrials.Gov:
https://clinicaltrials.gov

•Global Coronavirus COVID-19 Clinical Trial Tracker:
https://www.covid-trials.org/

•WHO Draft landscape of COVID-19 vaccine candidates:
https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

•Chief Scientist: The most promising vaccines for COVID-19:
https://www.chiefscientist.gov.au/sites/default/files/2020-05/rrif-covid19-promising-vaccines.pdf

•WHO: SAGE
https://www.who.int/immunization/policy/sage/en/